Interstitial lung disease associated with drug therapy

[1]  D. Fishwick.  PNEUMOTOX on line , 2005 .

[2]  David Cella,et al.  Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. , 2003, JAMA.

[3]  B. Forsythe,et al.  O-240 Clinical experience with gefitinib (‘Iressa’, ZD1839): an overview of safety and tolerability , 2003 .

[4]  G. Giaccone,et al.  P-615 Phase II trials of gefitinib (‘Iressa’, ZD1839): rapid and durable objective responses in patients with advanced non-small-cell lung cancer (IDEAL 1 and IDEAl 2) , 2003 .

[5]  M. Schaller,et al.  Relapsing acute respiratory failure induced by minocycline. , 2003, Chest.

[6]  M. Ebina,et al.  Severe acute interstitial pneumonia and gefitinib , 2003, The Lancet.

[7]  M. Akira,et al.  Drug-induced pneumonitis: thin-section CT findings in 60 patients. , 2002, Radiology.

[8]  N. Müller,et al.  Drug-induced lung disease: high-resolution CT and histological findings. , 2002, Clinical radiology.

[9]  David Harrington,et al.  Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. , 2002, The New England journal of medicine.

[10]  E. Yu,et al.  Computed tomography to assess pulmonary injury associated with concurrent chemo-radiotherapy for inoperable non-small cell lung cancer. , 2001, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[11]  R. Perng,et al.  Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere) , 2001, British Journal of Cancer.

[12]  K. Ask,et al.  Drug-induced infiltrative lung disease. , 2001, The European respiratory journal. Supplement.

[13]  N. Müller,et al.  Drug-induced lung disease: high-resolution CT findings. , 2000, AJR. American journal of roentgenology.

[14]  T. Colby,et al.  Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. , 2000, The European respiratory journal.

[15]  A. Cesne,et al.  Docetaxel and interstitial pulmonary injury. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  T. Taguchi,et al.  Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  P. Ros,et al.  Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. , 1995, Chest.

[18]  D. Tormey,et al.  The Eastern Cooperative Oncology Group , 1994 .

[19]  P. Herman,et al.  Exogenous lipoid pneumonia. , 1981, AJR. American journal of roentgenology.

[20]  J. Erasmus,et al.  Drug-induced lung injury. , 2002, Seminars in roentgenology.

[21]  R. Stahel,et al.  ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC). , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.